Incyte to Present at Upcoming Investor Conference

Rhea-AI Summary

Incyte will present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 12, 2022, at 12:30 p.m. EDT in New York. The presentation will be available via live webcast on Investor.Incyte.com and will be accessible for replay for 30 days. Based in Wilmington, Delaware, Incyte is a global biopharmaceutical company dedicated to addressing serious unmet medical needs through innovative therapeutics. For more information, visit Incyte.com.

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq:INCY) announced today that it will present at the Morgan Stanley 20^th Annual Global Healthcare Conference on Monday, September 12, 2022 at 12:30 p.m. (EDT) in New York.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220823005001/en/

Incyte

Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.com

Investors

Christine Chiou

+1 302 274 4773

cchiou@incyte.com

Source: Incyte

FAQ

When is Incyte's presentation at the Morgan Stanley Global Healthcare Conference?

Incyte's presentation is scheduled for September 12, 2022, at 12:30 p.m. EDT.

Where can I watch Incyte's presentation?

You can watch Incyte's presentation live on Investor.Incyte.com.

How long will Incyte's conference presentation be available for replay?

The presentation will be available for replay for 30 days after the event.

What is the focus of Incyte as a biopharmaceutical company?

Incyte focuses on finding solutions for serious unmet medical needs through the development of proprietary therapeutics.